Innospec Inc (NASDAQ: IOSP) has reported earnings for its third fiscal quarter (ending September 30) of $1.58 versus $1.56 for the same period a year ago — an increase of 1%. This result exceeded the […]
For its third fiscal quarter (ending September 30), Viatris Inc (NASDAQ: VTRS) has reported a -3% decline in E.P.S. from $0.29 a year ago to $0.28 in the current quarter. This performance was $-0.46 short […]
Ingredion Inc (NYSE: INGR) has reported E.P.S. of $2.39 for its third fiscal quarter (ending September 30) versus $1.61 for the same period a year ago — an increase of 48%. Relative to the consensus […]
Xencor Inc (NASDAQ: XNCR) has reported E.P.S. of $-0.40 for its third fiscal quarter (ending September 30) versus $-0.55 for the same period a year ago. This performance was $0.31 better than the consensus estimate […]
Mercury Systems Inc (NASDAQ: MRCY) has reported a loss for its first fiscal quarter (ending September 30) of $-0.64 versus a loss $-0.26 for the same period a year ago. This result fell short of […]
For its third fiscal quarter (ending September 30), National Research Corp (NASDAQ: NRC) has reported a -6% decline in E.P.S. from $0.34 a year ago to $0.32 in the current quarter. E.P.S. were $1.17 for […]
Premier Inc (NASDAQ: PINC) has reported E.P.S. of $0.38 for its first fiscal quarter (ending September 30) versus $0.36 for the same period a year ago — an increase of 6%. However, this performance was […]
The Mosaic Company (NYSE: MOS) has reported E.P.S. of $-0.01 for its third fiscal quarter (ending September 30) versus $2.45 for the same period a year ago — a decline of -100%. This performance was […]
Halozyme Therapeutics Inc (NASDAQ: HALO) stock enjoyed a major increase of 10.0% on 11/7/23. The shares closed at $38.80. The stock has performed in line with the market over the last nine months and has […]
Extremely important negative changes in investment behavior have recently occurred for Callon Petroleum Co/DE (NYSE: CPE): the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, and negative […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research